UN health agency issues alert on falsified medicines used for diabetes treatment, weight loss
The World Health Organization (WHO) on Thursday issued a medical product alert on the release of three batches of falsified semaglutides – the type of medicines primarily used to treat type 2 diabetes and obesity in some countries.
The spurious semaglutides – of a specific brand Ozempic – were found in Brazil, the United Kingdom in October 2023, and the United States in December 2023, and were delivered through a regular supply chain.
The WHO’s official notice follows reports of “falsified semaglutide products” across all geographical regions from its Global Surveillance and Monitoring System (GSMS) since 2022.
Dr. Yukiko Nakatani, WHO Assistant Director-General for Essential Medicines and Health Products called on all stakeholders to “stop any usage of suspicious medicines and report to relevant authorities.”
Risks
Ozempic’s actual manufacturer confirmed with WHO that the semaglutides were falsified based on batch and serial numbers.
Semaglutides are supposed to help people reduce their blood sugar and appetite levels and the risk of cardiovascular disease. WHO says reports of falsified products increased as demand for the product grew greater.
Consuming falsified or fake products can have harmful and life-threatening effects on one’s body.
Semaglutides are not recommended by WHO for diabetes treatment due to the product’s expensive cost.
Avoid fake products
Dr. Nakatani said the UN health agency advised healthcare professionals, regulatory authorities and the public to “be aware of these falsified batches of medicines.”
It added that healthcare professionals “should report any incident of adverse effects, lack of effectiveness and suspected falsification to the National Regulatory Authorities/National Pharmacovigilance Centre.”
WHO also advised individuals who may have fake products not to use them and to seek medical assistance if they have used them and experienced side effects.
Avoid unfamiliar sources
To avoid any such scenario, WHO urged people to purchase prescribed products from licensed physicians rather than online or from unfamiliar sources.
WHO added that people should use the products as prescribed and should check for lot and serial numbers, examine the product itself and assess the label quality to ensure the product being used isn’t falsified.
IBNS
Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.
Related Articles
UN issues dire warning: Asia faces rising cyclones and flooding like never before
Across southeast Asia, record-breaking rains and flooding caused by back-to-back tropical storms have claimed hundreds of lives and brought devastation and displacement upon entire communities, UN agencies said on Tuesday.
Hidden mental health cost of birth control pills? Study finds shocking link
A new study has suggested that the use of contraceptive pills may have a hidden cost: impaired mental health.
Stunning drop! India reports 49% fall in annual new HIV cases
The Indian government has announced that the country recorded a nearly 49 per cent decline in annual new HIV infections between 2010 and 2024.
WHO describes obesity as a 'chronic disease', backs wider use of weight-loss medicines
The UN World Health Organization (WHO) has issued its first guideline on the use of a new class of weight-loss medicines, marking a significant shift in global health policy as obesity rates continue to rise.
Latest News
Mosque in the middle of Kolkata airport? Centre confirms flight risks, BJP fires at Mamata
Prime Minister Mark Carney to attend FIFA World Cup 2026 Final Draw in Washington
Germany arrests two Iraqi nationals over suspected Islamic State links
Spanish tourist stabbed at Berlin Holocaust Memorial testifies in terror trial
